IgG Antibodies to GlcNAcβ and Asialo-Gm2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
Disease Markers - Egypt
doi 10.1155/2018/4639805
Full Text
Open PDFAbstract
Available in full text
Date
December 2, 2018
Authors
Publisher
Hindawi Limited